AMGN — AmgenIncorporated

Ownership history in JACOBS & CO/CA  ·  87 quarters on record

This page tracks every 13F SEC filing in which JACOBS & CO/CA reported a position in AmgenIncorporated (AMGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.57% (2022 Q4)
Avg. % of fund
1.33%
First filed
1999 Q1
Last filed
2025 Q4
Quarters held
87
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 43,579 -1,480 -3.3% 1.35% $14.3M $325.06
2025 Q3 ADDED 45,059 +1,078 +2.5% 1.22% $12.7M $278.27
2025 Q2 ADDED 43,981 +62 +0.1% 1.22% $12.3M $273.11
2025 Q1 REDUCED 43,919 -237 -0.5% 1.46% $13.7M $302.07
83 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    AMGN price (monthly, adj. close)

Other funds also holding AMGN

As of 2025 Q4 — sorted by position size

Round Hill Asset Management 3Y 7Y 8.47% Mizuho Markets Cayman LP 3Y 8.09% Oak Asset Management, LLC 3Y 7Y 6.41% JMAC ENTERPRISES LLC 3Y 5.66% GordonMD Global Investments LP 5.45% Smead Capital Management, Inc. 3Y 7Y 5.45% Ikarian Capital, LLC 3Y 5.11% Nepsis Inc. 3Y 7Y 5.1% Eliot Finkel Investment Counsel, LLC 3Y 7Y 4.97% Hofer & Associates. Inc 3Y 4.71%
← Back to JACOBS & CO/CA Holdings